Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: A population-based study (the Three-City cohort study)

Clinical Endocrinology

Volumn 77, Issue 6, 2012, Pages 905-910

  Canonico, Marianne ^a   Brailly Tabard, Sylvie ^b,c   Gaussem, Pascale ^c   Setiao, Julie ^b,c   Rouaud, Olivier ^d   Ryan, Joanne ^e   Carcaillon, Laure ^a,c   Guiochon Mantel, Anne ^b,c   Scarabin, Pierre Yves ^a  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b BICÊTRE HOSPITAL   (France)

^c INSERM   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

^e UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ESTRADIOL; FIBRINOGEN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEMENTIA; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FIBRINOGEN BLOOD LEVEL; FRANCE; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN LOCALIZATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TESTOSTERONE BLOOD LEVEL;

AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; ESTRADIOL; FEMALE; FIBRINOGEN; GONADAL STEROID HORMONES; HUMANS; OVERWEIGHT; POSTMENOPAUSE; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84869001202     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04448.x     Document Type: Article

References (37)

1. Uitte de Willige, S., Standeven, K.F., Philippou, H., et al,. (2009) The pleiotropic role of the fibrinogen gamma' chain in hemostasis. Blood, 114, 3994-4001.
2. Scarabin, P.Y., Aillaud, M.F., Amouyel, P., et al,. (1998) Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction-the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thrombosis and Haemostasis, 80, 749-756. (Pubitemid 28521717)
3. Danesh, J., Lewington, S., Thompson, S.G., et al,. (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA, 294, 1799-1809. (Pubitemid 41434626)
4. Carcaillon, L., Gaussem, P., Ducimetiere, P., et al,. (2009) Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study. Journal of Thrombosis and Haemostasis, 7, 1972-1978.
5. Rossouw, J.E., Prentice, R.L., Manson, J.E., et al,. (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA, 297, 1465-1477. (Pubitemid 46556472)
6. Rossouw, J.E., Anderson, G.L., Prentice, R.L., et al,. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333. (Pubitemid 34761611)
7. Anderson, G.L., Limacher, M., Assaf, A.R., et al,. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA, 291, 1701-1712. (Pubitemid 38489892)
8. Rexrode, K.M., Manson, J.E., Lee, I.M., et al,. (2003) Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation, 108, 1688-1693. (Pubitemid 37243655)
9. Lee, J.S., Yaffe, K., Lui, L.Y., et al,. (2010) Prospective study of endogenous circulating estradiol and risk of stroke in older women. Archives of Neurology, 67, 195-201.
10. Chen, Y., Zeleniuch-Jacquotte, A., Arslan, A.A., et al,. (2011) Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis, 216, 414-419.
11. Salpeter, S.R., Walsh, J.M., Ormiston, T.M., et al,. (2006) Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes, Obesity & Metabolism, 8, 538-554. (Pubitemid 44184248)
12. Folsom, A.R., Golden, S.H., Boland, L.L., et al,. (2005) Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women. European Journal of Epidemiology, 20, 1015-1022. (Pubitemid 41752620)
13. Sowers, M.R., Jannausch, M., Randolph, J.F., et al,. (2005) Androgens are associated with hemostatic and inflammatory factors among women at the mid-life. Journal of Clinical Endocrinology and Metabolism, 90, 6064-6071. (Pubitemid 41606526)
14. Sowers, M.R., Matthews, K.A., Jannausch, M., et al,. (2005) Hemostatic factors and estrogen during the menopausal transition. Journal of Clinical Endocrinology and Metabolism, 90, 5942-5948. (Pubitemid 41606509)
15. Maturana, M.A., Breda, V., Lhullier, F., et al,. (2008) Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism, 57, 961-965. (Pubitemid 351814689)
16. Stirling, Y., Woolf, L., North, W.R., et al,. (1984) Haemostasis in normal pregnancy. Thrombosis and Haemostasis, 52, 176-182. (Pubitemid 14024007)
17. Bremme, K., Ostlund, E., Almqvist, I., et al,. (1992) Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstetrics and Gynecology, 80, 132-137.
18. Bremme, K.A., (2003) Haemostatic changes in pregnancy. Best Practice & Research. Clinical Haematology, 16, 153-168.
19. Brenner, B., (2004) Haemostatic changes in pregnancy. Thrombosis Research, 114, 409-414. (Pubitemid 39422573)
20. Szecsi, P.B., Jorgensen, M., Klajnbard, A., et al,. (2010) Haemostatic reference intervals in pregnancy. Thrombosis and Haemostasis, 103, 718-727.
21. Thornton, P., &, Douglas, J., (2010) Coagulation in pregnancy. Best Practice & Research. Clinical Obstetrics & Gynaecology, 24, 339-352.
22. Trigg, D.E., Wood, M.G., Kouides, P.A., et al,. (2011) Hormonal influences on hemostasis in women. Seminars in Thrombosis and Hemostasis, 37, 77-86.
23. 3C study Group., (2003) Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology, 22, 316-325.
24. Carcaillon, L., Alhenc-Gelas, M., Bejot, Y., et al,. (2011) Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 1445-1451.
25. Raven, G., de Jong, F.H., Kaufman, J.M., et al,. (2006) In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. Journal of Clinical Endocrinology and Metabolism, 91, 3324-3328. (Pubitemid 44402098)
26. Larson, M.G., (2006) Descriptive statistics and graphical displays. Circulation, 114, 76-81. (Pubitemid 44305277)
27. Harnett, M.J., Bhavani-Shankar, K., Datta, S., et al,. (2002) In vitro fertilization-induced alterations in coagulation and fibrinolysis as measured by thromboelastography. Anesthesia and Analgesia, 95, 1063-1066, table of contents.
28. Ricci, G., Cerneca, F., Simeone, R., et al,. (2004) Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial. Human Reproduction, 19, 838-848. (Pubitemid 38456047)
29. Muller-Berghaus, G., Moeller, R.M., &, Mahn, I., (1978) Fibrinogen turnover in pregnant rabbits during the first and last thirds of gestation. American Journal of Obstetrics and Gynecology, 131, 655-660. (Pubitemid 8364341)
30. Stork, S., Bots, M.L., Grobbee, D.E., et al,. (2008) Endogenous sex hormones and C-reactive protein in healthy postmenopausal women. Journal of Internal Medicine, 264, 245-253.
31. Maggio, M., Ceda, G.P., Lauretani, F., et al,. (2011) SHBG, sex hormones, and inflammatory markers in older women. Journal of Clinical Endocrinology and Metabolism, 96, 1053-1059.
32. Maury, E., &, Brichard, S.M., (2010) Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and Cellular Endocrinology, 314, 1-16.
33. Alessi, M.C., Poggi, M., &, Juhan-Vague, I., (2007) Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Current Opinion in Lipidology, 18, 240-245. (Pubitemid 46743045)
34. Baglietto, L., English, D.R., Hopper, J.L., et al,. (2009) Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition. Breast Cancer Research and Treatment, 115, 171-179.
35. Borissoff, J.I., Spronk, H.M., &, ten Cate, H., (2011) The hemostatic system as a modulator of atherosclerosis. New England Journal of Medicine, 364, 1746-1760.
36. Stanczyk, F.Z., Jurow, J., &, Hsing, A.W., (2010) Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies. Cancer Epidemiology, Biomarkers & Prevention, 19, 903-906.
37. Scarabin, V., Canonico, M., Brailly-Tabard, S., et al,. (2012) High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the Three-City cohort study. Journal of the American Heart Association, in press.